What was the market valuation of the US bacterial cell-culture market in 2024?

The market valuation was $540.98 Million in 2024. Read More

What is the projected market valuation for the US bacterial cell-culture market by 2035?

The projected valuation for 2035 is $1100.0 Million. Read More

What is the expected CAGR for the US bacterial cell-culture market during the forecast period 2025 - 2035?

The expected CAGR is 6.66% during the forecast period 2025 - 2035. Read More

Which companies are considered key players in the US bacterial cell-culture market?

Key players include Thermo Fisher Scientific, Merck KGaA, Becton Dickinson and Company, and others. Read More

What are the main product segments in the US bacterial cell-culture market?

The main product segments are Equipment and Consumables, with Consumables valued at $340.98 Million to $700.0 Million. Read More

What applications are driving the US bacterial cell-culture market?

Applications include Biopharmaceutical, Cytogenetic, Food Testing, and others, with Biopharmaceutical valued at $200.0 Million to $400.0 Million. Read More

Who are the primary targeted audiences for the US bacterial cell-culture market?

Primary audiences include Healthcare organizations, Research and development companies, and others, with Healthcare organizations valued at $120.0 Million to $240.0 Million. Read More

What are the end-user segments in the US bacterial cell-culture market?

End-user segments include Hospitals and Diagnostic Centers, Academic and Research Laboratories, and others, with Academic and Research Laboratories valued at $180.0 Million to $360.0 Million. Read More

How does the market size for Equipment compare to Consumables in the US bacterial cell-culture market?

Equipment is valued between $200.0 Million and $400.0 Million, whereas Consumables range from $340.98 Million to $700.0 Million. Read More

What trends are expected to influence the US bacterial cell-culture market in the coming years?

Trends may include advancements in biopharmaceutical applications and increased demand from healthcare organizations, potentially driving growth. Read More

US Bacterial Cell Culture Market

ID: MRFR/LS/17758-HCR

100 Pages

Rahul Gotadki

Last Updated: May 13, 2026

US Bacterial Cell Culture Market Research Report By Product (Consumables, Equipment, others), By Application (Biopharmaceutical, Cytogenetic, Food Testing, Water Testing, others) and By End User (Hospitals and Diagnostic Centers, Academic and Research Laboratories, Biopharmaceutical Companies, others) - Growth & Industry Forecast 2025 To 2035

US Bacterial Cell Culture Market Infographic

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Construction, BY Product (USD Million) | |
  1. 4.1.1 Equipment | |
  2. 4.1.2 Consumables |
2. 4.2 Construction, BY Application (USD Million) | |
  1. 4.2.1 Biopharmaceutical | |
  2. 4.2.2 Cytogenetic | |
  3. 4.2.3 Food Testing | |
  4. 4.2.4 Water Testing | |
  5. 4.2.5 Others |
3. 4.3 Construction, BY Targeted Audience (USD Million) | |
  1. 4.3.1 Cell culture media manufacturing companies | |
  2. 4.3.2 Healthcare organizations | |
  3. 4.3.3 Healthcare providers | |
  4. 4.3.4 Government organizations | |
  5. 4.3.5 Contract manufacturing organization (CMO) | |
  6. 4.3.6 Research and development (R&D) companies |
4. 4.4 Construction, BY End-User (USD Million) | |
  1. 4.4.1 Hospitals and Diagnostic Centers | |
  2. 4.4.2 Academic and Research Laboratories | |
  3. 4.4.3 Biopharmaceutical Companies | |
  4. 4.4.4 Others 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Construction | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Thermo Fisher Scientific (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Merck KGaA (DE) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Becton Dickinson and Company (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Lonza Group (CH) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Corning Incorporated (US) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 GE Healthcare (GB) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Sigma-Aldrich (US) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 F. Hoffmann-La Roche Ltd (CH) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 US MARKET ANALYSIS BY PRODUCT |
6. 6.3 US MARKET ANALYSIS BY APPLICATION |
7. 6.4 US MARKET ANALYSIS BY TARGETED AUDIENCE |
8. 6.5 US MARKET ANALYSIS BY END-USER |
9. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION |
10. 6.7 RESEARCH PROCESS OF MRFR |
11. 6.8 DRO ANALYSIS OF CONSTRUCTION |
12. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION |
13. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION |
14. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION |
15. 6.12 CONSTRUCTION, BY PRODUCT, 2024 (% SHARE) |
16. 6.13 CONSTRUCTION, BY PRODUCT, 2024 TO 2035 (USD Million) |
17. 6.14 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE) |
18. 6.15 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million) |
19. 6.16 CONSTRUCTION, BY TARGETED AUDIENCE, 2024 (% SHARE) |
20. 6.17 CONSTRUCTION, BY TARGETED AUDIENCE, 2024 TO 2035 (USD Million) |
21. 6.18 CONSTRUCTION, BY END-USER, 2024 (% SHARE) |
22. 6.19 CONSTRUCTION, BY END-USER, 2024 TO 2035 (USD Million) |
23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
24. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million) | |
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million) | |
  3. 7.2.3 BY TARGETED AUDIENCE, 2025-2035 (USD Million) | |
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million) |
26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.3.1 |
27. 7.4 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

US Construction Market Segmentation

Construction By Product (USD Million, 2025-2035)

Equipment
Consumables

Construction By Application (USD Million, 2025-2035)

Biopharmaceutical
Cytogenetic
Food Testing
Water Testing
Others

Construction By Targeted Audience (USD Million, 2025-2035)

Cell culture media manufacturing companies
Healthcare organizations
Healthcare providers
Government organizations
Contract manufacturing organization (CMO)
Research and development (R&D) companies

Construction By End-User (USD Million, 2025-2035)

Hospitals and Diagnostic Centers
Academic and Research Laboratories
Biopharmaceutical Companies
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓